OVERVIEW

Illuminating the Darkness: Depression Guideline Update is organized by CEimpact.

Initial Release Date: September 11, 2023
Planned Expiration Date: September 12, 2026

Description:
Pharmacists are a trusted resource for patients navigating the financial struggles, societal stigma, and overall darkness associated with depression. Our review of the pathophysiology, diagnosis criteria, and assessments related to depression and our thorough discussion on guideline-based treatment approaches will assist you as you embrace your role of caring for patients with major depressive disorder.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
• List the signs, symptoms, and diagnostic criteria of major depressive disorder (MDD)
• Apply guideline-based treatment algorithms to persons with MDD
• Develop monitoring plans for persons with MDD and medications used to treat MDD
• Formulate evidence-based recommendations for persons with MDD
• Discuss the role of the pharmacy team in the patient journey for persons with MDD

Additional details will be posted as soon as information is available.